Skip to content

Welcome to Discover Pharma! Today is : October 28, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

fibrosis

  • Digital & Data,Drug Discovery & Development,Research & Development

    Shift Bioscience publishes AI virtual cell framework for target discovery

    Shift Bioscience has published research in Nature Biotechnology describing a [...]

    October 6, 2026
  • Advanced Therapies,Drug Discovery & Development,Therapeutic Areas

    Resolution Therapeutics expands regenerative macrophage pipeline with in vivo mRNA programme

    Resolution Therapeutics has expanded its regenerative macrophage therapy pipeline with [...]

    June 18, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035

    Syngene International has extended its strategic collaboration with Bristol Myers [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Persista Bio wins NIH funding to advance O2Line cell therapy

    Persista Bio has been awarded two grants from the US [...]

    May 5, 2026
  • Drug Discovery & Development,Opinion & Events

    Vitamin D shown to reduce liver damage by activating TXNIP gene, study finds

    New study shows how the vitamin D/TXNIP axis modulates ductular [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Therapeutic Areas

    AI validation of rentosertib efficacy supports global trial expansion in IPF

    Qureight’s deep-learning biomarkers confirm representativeness of Insilico’s Phase 2a IPF [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development

    Ochre Bio founder takes helm as CEO to drive RNA liver therapies towards clinic

    RNA therapeutics biotech Ochre Bio has appointed its founder and [...]

    May 5, 2026
  • Advanced Therapies

    Hydrogel breakthrough could boost liver cell therapy durability, Likarda paper shows

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Johnson & Johnson reports three-year Crohn’s disease results for guselkumab
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Ryvu reports preclinical results for novel ADC payload
    Categories: Drug Discovery & Development, Research & Development
  • Kindeva wins $226 million contract for nerve agent antidote autoinjectors
    Categories: Manufacturing & Supply Chain
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top